Visgeneer Inc. (TPEX:4197)
Taiwan · Delayed Price · Currency is TWD 9.85
+0.01 (0.10%)
Feb 11, 2026, 2:51 PM CST
Visgeneer Market Cap
Visgeneer has a market cap or net worth of 297.28 million as of February 13, 2026. Its market cap has increased by 0.82% in one year.
Market Cap
297.28M
Enterprise Value
331.32M
Revenue
159.76M
Ranking
n/a
PE Ratio
n/a
Stock Price
9.85
Market Cap Chart
Since October 24, 2013, Visgeneer's market cap has decreased from 898.66M to 297.28M, a decrease of -66.92%. That is a compound annual growth rate of -8.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 297.28M | 1.55% |
| Dec 31, 2025 | 292.75M | -0.72% |
| Dec 31, 2024 | 294.87M | -8.69% |
| Dec 29, 2023 | 322.94M | 1.90% |
| Dec 30, 2022 | 316.90M | -17.97% |
| Dec 30, 2021 | 386.32M | -8.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eusol Biotech | 1.05B |
| Taiwan Advance Bio-Pharmaceutical | 990.00M |
| TCI GENE | 986.90M |
| NatureWise Biotech & Medicals | 982.35M |
| Neith | 974.70M |
| SynCore Biotechnology Co.,Ltd | 771.87M |
| BioLASCO Taiwan | 761.96M |
| TaiwanJ Pharmaceuticals | 616.94M |